J Neuroinflammation 20(1):147 Parmar DV, Kansagra KA, Momin T, Patel HB, Jansari GA, Bhavsar J et al (2023) Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1: first-in-human phase 1 studies (single ascending dose and multiple ascending dose)
V.PolishchukR
Label states no soy, wheat, lactose, starch, or artificial flavors
its effects can be felt as far away as the brain, heart, liver, kidneys, and more
Often referred to as the bodys master antioxidant, glutathione plays a central role in detoxification, cellular repair, and immune regulation
Post-injection soreness (described as muscle ache similar to post-vaccine soreness) occurs in 41% of patients and lasts 24-36 hours